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lac permease mutated at each of the 8 cysteinyl  res- 
idues in the molecule was solubilized from the mem- 
brane, purified, and reconstituted into proteolipo- 
somes. The transport activity of proteoliposomes re- 
constituted with each mutant permease relative to the 
wild-type is virtually identical with that reported for 
intact cells and/or right-side-out membrane vesicles. 
Moreover, a  double  mutant containing Ser  in place of 
both Cys14' and CydS4 exhibits significant ability to 
catalyze  active lactose transport. The results provide 
strong confirmation for the contention that cysteinyl 
residues in lac permease do not play an important role 
in the transport mechanism. The effect of sulfhydryl 
oxidant 6-hydroxy-2-methyl-1,4-maphthoquinone on 
lactose transport in proteoliposomes reconstituted with 
wild-type or  mutant permeases was  also  investigated, 
and the results indicate that inactivation is probably 
due to formation of a covalent adduct with CYS'~' and/ 
or CYS''~ rather than disulfide formation. Thus, it 
seems unlikely that sulfhydryl-disulfide interconver- 
sion functions to regulate permease activity. 
The lactose (lac) permease of Escherichia coli is a hydro- 
phobic polytopic cytoplasmic membrane protein that cata- 
lyzes concomitant translocation of @-galactosides and H' with 
a stoichiometry of 1:l (i.e. lactose/H+  cotransport or symport) 
(cf. Refs. 1-4 for reviews). Encoded by the lacy gene that has 
been cloned and sequenced, this prototype membrane trans- 
port protein has been solubilized from the membrane, purified 
to homogeneity, reconstituted  into proteoliposomes, and dem- 
onstrated  to be solely responsible for @-galactoside transport. 
Based on circular dichroic measurements with purified per- 
mease and hydropathy analysis of the primary amino acid 
sequence (5), a secondary structure has been proposed in 
which the protein consists of 1 2  hydrophobic domains in a- 
helical conformation that traverse the membrane in zig-zag 
fashion, connected by hydrophilic segments with the N and 
C  termini on the cytoplasmic surface (cf. Fig. 1). The general 
features of the model are  consistent with other spectroscopic 
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measurements (6),' chemical modification (7), limited prote- 
olysis (8,9),  and immunological studies (10-16). Furthermore, 
recent studies (17) on an extensive series of lac permease- 
alkaline phosphatase (lac- Y-phoA) fusion proteins provide 
strong  and exclusive support for the topological predictions 
of the 12-helix model. 
As demonstrated initially by  Fox et al. (18) and Kennedy 
et al. (19), the lac permease is irreversibly inactivated by N- 
ethylmaleimide, and protection is afforded by substrates such 
as &D-galactopyranosyl-@,D-thiogalactopyranoside. On the 
basis of these findings, it was postulated (18) that a cysteinyl 
residue is at or near the substrate-binding  site of lac permease. 
Beyreuther et al. (20) later showed that  the substrate-protect- 
able residue is CYS'~~.  In addition, the permease is reversibly 
inactivated by other sulfhydryl reagents such as p-chloro- 
mercuribenzenesulfonate or by sulfhydryl oxidants such as 
diamide (21) or plumbagin' (22), and ~,D-galactopyranosyl- 
@,D-thiogalactopyranoside prevents inactivation by these re- 
agents. Because of the  latter observations, it was suggested 
(22, 23) that permease activity may  be regulated by a redox 
process involving sulfhydryl-disulfide interconversion. 
Given the importance attributed  to sulfhydryl groups in lac 
permease (cf. Ref. 24 in addition to arguments presented 
above), particularly CYS'~', site-directed mutagenesis was  used 
to replace Cys14' with Gly (25,26) or Ser (27,28). Surprisingly, 
although C Y S ' ~ ~  is required for substrate protection against 
alkylation by N-ethylmaleimide, it is not  important for lac- 
tose/H+ symport. Subsequently, it was shown (2, 29) that 
replacement of C Y S ' ~ ~  with Gly leads to complete loss of 
transport activity, although the permease retains the ability 
to bind the high affinity ligand p-nitrophenyl-a,D-galactopy- 
ranoside. Moreover, replacement of C Y S ' ~ ~  with Ser or Val 
yields permease with 10% or 30%, respectively, of wild-type 
activity, indicating that, although C Y S ' ~ ~  is important for full 
activity, it is not mandatory. Finally, Brooker and Wilson 
(30) replaced C Y S ' ~ ~  or Cys234 with Ser, and Menick et al. (31) 
replaced Cys'17, Cys333 or Cys353 and Cys355 with Ser and 
observed little or no effect on permease activity. Therefore, 
out of a  total of 8 cysteinyl residues in the permease, only 
C Y S ' ~ ~  appears to be important for transport,  and even this 
residue is not absolutely essential. 
Although the results from site-directed mutagenesis provide 
strong evidence that cysteinyl residues in the permease do 
not play a direct role in the mechanism, alkylation of CYS'~' 
In addition to circular dichroism and laser Raman spectroscopy, 
Fourier transform infrared studies also show that purified lac per- 
mease is largely helical (P. D. Roepe, H. R. Kaback, and K. J. 
Rothschild, unpublished work). 
The abbreviations used are: plumbagin, 5-hydroxy-2-methyl-l,4- 
naphthoquinone; DTT, dithiothreitol. 
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FIG. 1. Secondarystructuremodel 
of lac permease based on the hy- 
dropathy of the deduced amino acid 
sequence (5 )  with  cysteinyl residues 
(C)  highlighted. The single-letter 
amino acid code is used. 
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or replacement of C y P 4  with Gly leads to inactivation.  Fur- 
thermore, Cys14* and C Y S ' ~ ~  are  both located in  putative trans- 
membrane helix V (Fig. 1) and are predicted to be on the 
same face. Therefore, an attractive explanation for inactiva- 
tion by sulfhydryl oxidants is catalysis of disulfide formation 
between these 2 residues. In order to test  this possibility, we 
have solubilized and purified each site-directed Cys mutant 
in  the permease, as well as a double mutant  containing  Ser in 
place of both CYS'~'  and CYS'~~,  and stu ied transport activity 
and inactivation by plumbagin in reconstituted proteolipo- 
somes. The results indicate that permease inactivation by the 
sulfhydryl oxidant results from formation of a covalent adduct 
with either Cys14* or C y P 4  and  not from disulfide formation. 
EXPERIMENTAL  PROCEDURES 
Materials 
[1-"CILactose (57 mCi/mmol) was obtained from Amersham 
(Buckinghamshire, U. K.). All other reagents were obtained as de- 
scribed (32, 33) and were reagent grade. 
Methods 
Bacterial Strains and Plasmids-E. coli T206, E. coli T184, and 
plasmid pGM21 encoding wild-type lac-Y (34) or lac-Y with site- 
directed mutants  in single Cys codons (25-31) have been described. 
Construction of C148S/C154S3 Double Mutant-Starting with the 
M13 mp18 (lac-Y) DNA containing  a  Ser codon at position 148 (25), 
the double mutant containing C148S/C154S was constructed as de- 
scribed by Menick et al. (29). Subsequently, mutations were confirmed 
by sequencing the entire lac-Y gene in single-stranded M13 mp18 
DNA and  the region containing the mutations in plasmid pGM21. In 
both cases, with the exception of the mutations described, the re- 
Buchel et al. (35). 
mainder of the lac-Y sequence was identical with that reported by 
Cell  Growth-E.  coli T184 transformed with a given plasmid was 
grown and induced with isopropyl-1-thio-&D-galactopyranoside as 
described by Teather et al. (341, with the exception that 0.2-0.596 
'' Site-directed mutants are designated as follows. The one-letter 
amino acid code is used followed  by a number indicating the position 
of the residue in the wild-type lac permease. This is followed by a 
second letter denoting the amino acid replacement at  this position 
(e.g. C148S designates that Cys14' is replaced by Ser). 
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casamino acid was used in place of methionine and  threonine in the 
growth medium (36). 
Purification and Reconstitution of lac Permease-Wild-type and 
mutant lac permeases were solubilized, purified, and reconstituted 
into proteoliposomes as described (32), except that  the '2148s and 
C148G permeases were reconstituted  into proteoliposomes by over- 
night dialysis instead of detergent dilution. In  addition,  after freeze- 
thawing, the proteoliposomes were not sonified, but extruded through 
polycarbonate filters of 100-nm pore size, using an extrusion device 
(Lipex Biomembranes, Vancouver). This procedure yields proteoli- 
posomes of a relatively uniform size distribution (37). The final 
preparations  contained proteoliposomes at 37.5 mg of E. coli phos- 
pholipids/ml and 40-90 pg/ml of protein, as indicated, in 50 mM KP,, 
pH 7.5, 1.0 mM DTT. 
Transport Assays-Membrane potential (Aq)-driven lactose trans- 
port in proteoliposomes reconstituted with purified permeases was 
assayed in the presence of a potassium diffusion potential (interior 
negative) as described (32). 
Protein Determinations-Protein was determined by the method 
of Schaffer and Weissmann (38). 
RESULTS 
A@-Driven Lactose Accumulation-As demonstrated pre- 
viously  (39-42), proteoliposomes reconstituted with purified 
lac permease rapidly accumulate lactose against  a  concentra- 
tion gradient in the presence of the potassium diffusion gra- 
dient (Kin + KO,,) and  the ionophore valinomycin (Fig. 2). 
Under identical conditions, proteoliposomes reconstituted 
with purified C117S,  C148S,  C176S,  C234S,  C333S, or C353S/ 
C355S transport lactose at initial  rates to steady-state levels 
of accumulation that  are comparable with proteoliposomes 
reconstituted with wild-type permease (cf. Table  I for quan- 
titation of initial rates relative to wild-type). In contrast, 
proteoliposomes reconstituted with C148G,  C154S, or C154V 
transport lactose at initial rates that  are about 15, 10, and 
35% respectively, of wild-type proteoliposomes (Fig. 2 and 
Table  I). In each instance, the level of accumulation continues 
to increase as  the time course of the experiments is extended 
(Fig. 2; data  not shown). Finally, proteoliposomes reconsti- 
tuted with C148S/C154S permease transport at about 5% the 
rate of wild-type but  continue to accumulate the disaccharide 
with time, whereas proteoliposomes reconstituted with C154G 
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FIG. 2. Membrane potential (A*)-driven lactose transport 
in proteoliposomes reconstituted  with  purified  wild-type (O), 
C148G (O), C154G (A), C154S (m), C154V (0) or C148S/ 
C l S 4 S  (V) lac permease. lac permease was purified from mem- 
branes of E. coli T206 or T184 transformed with the appropriate 
plasmid and reconstituted into proteoliposomes at a  protein concen- 
tration of 85 pg/ml (wild-type), 75 pg/ml (C148G), 45 pg/ml (C154G), 
70 Ng/ml (C154S), 65 pg/ml (C154V), or 40 pg/ml (C148S/C154S). 
Lactose transport was measured as described (32) by diluting 1 pl of 
proteoliposomes containing 20 p~ valinomycin into 200 pl of 50 mM 
sodium phosphate (pH 7.5) containing 35 p~ [l-'4C]lactose (57 mCi/ 
mmol). Control experiments (A) were performed by diluting 1 pl of 
proteoliposomes into 50 mM potassium phosphate (pH 7.5). 
TABLE I 
Initial  rate of A*-driven  lactose transport in proteoliposomes 
reconstituted with  wild-type or mutant lac permease 




























Initial rates of transport were calculated from the initial  linear 
The turnover number for wild-type permease in this preparation 
portion of transport curves (cf. Fig. 2). 
was 16 s". 
permease are essentially devoid of transport activity (Fig. 2; 
Table I). 
Effect of Plumbagin-Treatment of right-side-out mem- 
brane vesicles with the sulfhydryl oxidant plumbagin at a 
concentration of 0.5 mM leads to complete inactivation of 
lactose transport  in  a  manner  that  can be restored by 10 mM 
DTT (22). Similar phenomena are observed in proteolipo- 
somes reconstituted with purified lac permease. Thus, A P -  
driven lactose transport is progressively inactivated by rela- 
tively low concentrations of plumbagin, and maximal inacti- 
vation is observed at about 0.5 mM (Figs. 3 and 4A). Moreover, 











0 200 400 600 800 
[plumbagin] (1M) 
FIG. 3. Titration of lactose transport with plumbagin in 
proteoliposomes reconstituted with purified wild-type lac 
permease. Proteoliposomes were incubated at room temperature for 
30 min with different concentrations of plumbagin. Subsequently, the 
initial  rate of Al-driven lactose transport was measured as in  Table 
I. 
" 0 1 2 3 4 5 6  
TIME (min) 
z 5 e; 1 
0.0 
0 1 2 3 4 5 6  
TIME (min) 
FIG. 4. Effect of 0 . 5  mM plumbagin and 1 0  mM DTT on 
lactose transport  in proteoliposomes reconstituted  with  puri- 
fied wild-type permease ( A )  or C148S/C154S permease ( B ) .  
Proteoliposomes were incubated at room temperature for 30 min with 
or without 0.5 mM plumbagin and  then incubated for 30 min with or 
without 10 mM DTT  as indicated. Subsequently, A*-driven lactose 
transport was measured as in Fig. 2 with an  external concentration 
of 35 p~ [l-"C] lactose (57 mCi/mmol). 0, plumbagin; ., plumbagin 
followed by DTT; 0 10 mM DTT; 0, no additions; A, control exper- 
iments, performed by diluting 1 pl of proteoliposomes into 50 mM 
potassium phosphate (pH 7.5). 
posomes with plumbagin, transport is restored to a great 
extent (Fig. 4A; Table 11). Parenthetically, when the proteo- 
liposomes are washed and resuspended in buffer without 
addition of DTT, lac permease is apparently slightly inacti- 
vated by air oxidation, as evidenced by the observation that 
addition of DTT by itself causes a small stimulation of trans- 
port activity. 
Results of similar experiments carried out on proteolipo- 
somes reconstituted with each mutant permease are  summa- 
rized in Table 11. The initial  rate of AP-driven lactose trans- 
port in proteoliposomes reconstituted with C117S, C148S, 
C154V, C176S, C234S, C333S, or C353s/C355s is essentially 
completely inactivated by treatment with 0.5 mM plumbagin, 
and activity is restored by addition of 10 mM DTT in each 
instance.  In  contrast, C148G or (2154s permease is inactivated 
by only about 50%, and strikingly, C148S/C154S permease 
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Cysteine  Mutants of lac Permease 15691 
TABLE I1 
Inhibition of the initial rate of A*-driven lactose transport  with 0.5 
mMplumbagin  in proteoliposomes reconstituted with mutant 
permeases and the  restoration of activity by DTT 
Initial rates of lactose transport were measured as in Table I. 
Proteoliposomes were treated with plumbagin and  DTT  as described 
in  the legend to Fig. 4. 
Residual  activity after plumbagin Restoration of 
inhibition 
Permease activity by DTT 
% % 
Wild-type 0 90 
C117S 8 85 
C148S 0 95 
C148G 48 70 
C154S 50 80 
C154V 7 100 
C148S/C154S 80 100 
C176S 0 90 
C234S 0 85 
C333S 0 78 
C353S/C355S 0 100 
(Fig. 4B) is only marginally inactivated by the sulfhydryl 
oxidant. Although the  transport  activity of C148G, C154S, or 
C148S/C154S permease is low, accumulation of lactose in 
proteoliposomes reconstituted with these permeases clearly 
increases  with  time before and  after  treatment  with  plumba- 
gin (Fig. 4B).  In  contrast, proteoliposomes reconstituted  with 
wild-type permease  or  any of the  other  mutants  exhibit  no 
accumulation of lactose  after  treatment with plumbagin (Fig. 
4A 1. 
DISCUSSION 
The  data  presented  in  this  paper provide strong  confirma- 
tion of the conclusion that  cysteinyl residues in lac permease 
do not play a direct role in the mechanism of lactose/H+ 
symport (2, 25-31). Proteoliposomes  reconstituted  with  puri- 
fied permease molecules containing  mutations a t  each  indi- 
vidual cysteinyl  residue exhibit  transport  activities  relative  to 
wild-type proteoliposomes that are virtually identical with 
those  reported for intact cells and/or  right-side-out  membrane 
vesicles. Specifically, purified permease  with C117S, C148S, 
C176S, C234S, C333S, or C353S/C355S exhibits  small if any 
defects in A*-driven lactose accumulation, permease with 
C148G, C154S, or C154V exhibits reduced rates of lactose 
uptake,  and C154G permease  is devoid of transport  activity. 
Importantly,  the double mutant C148S/C154S exhibits low 
but  significant activity.  Clearly, therefore,  although C Y S ' ~ ~  is 
important for substrate  protection  against  N-ethylmaleimide 
inactivation (18, 20), C Y S ' ~ ~  is the only cysteinyl residue in 
the permease that is important for activity; but even this 
residue  is  not obligatory. 
Although  cysteinyl  residues do  not play  a direct role in  the 
mechanism of lac permease, based on the observation that 
sulfhydryl oxidants reversibly inactivate  lactose/H+  symport, 
it  was suggested that sulfhydryl-disulfide interconversion may 
have a regulatory function (22). Since  alkylation of CYS'~' or 
replacement of C Y S ' ~ ~  with Gly leads  to  inactivation  and  these 
residues  should  be  on  the  same face of putative helix V, the 
effect of the sulfhydryl oxidant  plumbagin  on  lactose  trans- 
port by proteoliposomes reconstituted  with  each  site-directed 
Cys mutant was  investigated. As discussed, one possible  mech- 
anism of inactivation  is  that  the  sulfhydryl  oxidant  catalyzes 
disulfide formation between  CYS'~' and   CYS'~~.  Alternatively, 
since modification of either C Y S ' ~ ~  or C Y S ' ~ ~  alone  can lead to 
inactivation,  it  is possible that disulfide formation between 
either of these residues and  another cysteinyl  residue in  the 
permease causes inactivation. Finally, sulfhydryl oxidants 
may undergo "half-reactions" with  cysteinyl  residues  (21, 43, 
44), thereby forming sulfhydryl adducts without catalyzing 
disulfide formation.  Our  results favor the  last possibility  for 
the following reasons. (i) Plumbagin treatment leads to a 
marked inactivation of C117S, C176S, C234S, C333S, or 
C353S/C355S permease, suggesting that  none of these cystei- 
nyl  residues is involved in  the  phenomenon.  Consequently,  it 
is unlikely that mixed  disulfide formation between C Y S ' ~ ~  or 
C Y S ' ~ ~   a n d  any of the  other cysteinyl  residues in  the  permease 
is responsible for  inactivation.  (ii) The double mutant C148S/ 
C154S, which has a low but  significant  activity,  is  resistant 
to  inactivation by plumbagin,  thereby  demonstrating directly 
that  Cyd4'  and/or C y P 4  are  the residues involved. (iii) The 
single mutants C148S and C154V are  essentially completely 
inactivated by the sulfhydryl oxidant, whereas C148G or 
C154S permease are partially inactivated. Thus, a single 
cysteinyl  residue at either of these  positions  is sufficient  for 
inactivation by plumbagin, a result  not expected if disulfide 
formation between the residues is required  for inactivation. 
In conclusion,  since it  is unlikely that  permease  inactivation 
by sulfhydryl oxidants involves the formation of disulfide 
bonds, sulfhydryl-disulfide interconversion probably  does not 
have a regulatory function  in  the  activity of this  transport 
protein. 
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